The Department of Health, Disability and Ageing has issued Legislative Instrument F2026L00408, amending the National Health (Listing of Pharmaceutical Benefits) Instrument 2024 (PB 26 of 2024) under authority of the National Health Act 1953. This April 2026 update modifies the Pharmaceutical Benefits Scheme schedules, typically adding new medicines, adjusting pricing, or updating listing conditions for existing PBS items.

Pharmaceutical companies should verify their products remain correctly listed and update any associated documentation. Healthcare providers should ensure prescribing systems reflect the latest PBS schedule. Patients may be affected by changes to medicine availability, pricing, or access conditions. This is a routine administrative update to the PBS and does not impose new compliance burdens beyond standard pharmaceutical listing requirements.